02Dec

Manage Waste Medicines & Ensure Compliance  

 

Now available from Alpha Laboratories is the Safer Options range of Controlled Drug Denature Kits which can help you safely manage waste medicines and comply with legislation more easily and effectively. 
 
Manufactured in the UK, these denature kits are simple and easy to use. Waste medicines – tablets, liquids, patches etc. are placed in the jar with the water-soluble sachet of denaturing formula. Water is then added to the designated level and the jar closed and shaken to mix the denaturing formula with the water and controlled drugs.
 
The denaturing formula congeals and denatures the drugs in a couple of minutes and the kit can then be placed in a secure pharmaceutical waste container prior to incineration. The denaturing formula has a bitter taste as an additional deterrent and is contained in a sachet to protect against spillage.  Full instructions appear on every container so there is no pack insert to get lost, especially when splitting up multipacks for use in separate locations.
 
Under the Misuse of Drugs Regulations (2001) obsolete controlled drugs (CDs) must be destroyed by being denatured and rendered irretrievable before being placed into pharmaceutical waste containers.  These new controlled drugs denature kits are an innovative and unique solution helping hospitals, pharmacies, hospices, care homes and other healthcare providers to safely manage waste medicines and comply with this legislation. 
 
The kits are available in six container volumes and a range of pack sizes providing multiple options to suit your working needs.
 
Please visit www.alphalabs.co.uk/denaturekits for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

Maintain Sample Integrity with New RNA Complete BCT™

New RNA Complete BCT™ is a direct draw blood collection tube, now available in the UK from Alpha La...

Read More >

Isohelix Double Registers its DNA Saliva and Buccal Cell Collectors with the Chinese CFDA.

Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors ar...

Read More >

Game Changer for Bladder Cancer Diagnosis

ADXBLADDER, an exciting new non-invasive test for bladder cancer from Arquer Diagnostics Ltd. and di...

Read More >

SpeeDx and Diagen sign new distribution agreement for Scandinavia

SYDNEY, AUSTRALIA – (Sept 19, 2017). SpeeDx Pty, Ltd. has announced a distribution agreement with D...

Read More >

MBM and OCB launch ColoProg in China on March 7th 2018

Oxford developed prognostic assay for risk of post-surgical recurrence in Stage II colorectal cance...

Read More >

Rapid free light chain test granted registration in Brazil

Seralite®– FLC Serum granted registration by the Brazilian Health Regulatory Agency (ANVISA) Abing...

Read More >